To assess the safety and tolerability of single ascending intravenous (IV) doses of EI-001 in healthy volunteers~To assess the pharmacokinetics (PK) of single ascending IV doses of EI-001 in healthy volunteers
A First-in-Human, Phase 1, Randomized, Double-Blind, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of EI-001 in Healthy Volunteers.